Found: 7
Select item for more details and to access through your institution.
Blood-brain barrier permeability increases with the differentiation of glioblastoma cells in vitro.
- Published in:
- Fluids & Barriers of the CNS, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12987-024-00590-0
- By:
- Publication type:
- Article
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03142-4
- By:
- Publication type:
- Article
Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03142-4
- By:
- Publication type:
- Article
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, p. 1, doi. 10.1186/s13046-024-03142-4
- By:
- Publication type:
- Article
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02447-6
- By:
- Publication type:
- Article
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02284-7
- By:
- Publication type:
- Article